Seed Wealth Management Inc. Trims Stock Position in CVS Health Co. (NYSE:CVS)

Seed Wealth Management Inc. decreased its holdings in shares of CVS Health Co. (NYSE:CVS) by 8.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,055 shares of the pharmacy operator’s stock after selling 280 shares during the quarter. Seed Wealth Management Inc.’s holdings in CVS Health were worth $243,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of CVS. Norges Bank purchased a new position in shares of CVS Health during the fourth quarter worth $1,092,040,000. Capital International Investors increased its stake in CVS Health by 47.4% during the fourth quarter. Capital International Investors now owns 33,691,698 shares of the pharmacy operator’s stock worth $2,660,298,000 after purchasing an additional 10,837,801 shares during the period. Clearbridge Investments LLC boosted its stake in shares of CVS Health by 306.6% in the fourth quarter. Clearbridge Investments LLC now owns 3,046,216 shares of the pharmacy operator’s stock valued at $240,529,000 after purchasing an additional 2,297,100 shares during the period. Junto Capital Management LP acquired a new position in shares of CVS Health in the fourth quarter valued at approximately $111,209,000. Finally, International Assets Investment Management LLC lifted its holdings in CVS Health by 8,697.2% during the 4th quarter. International Assets Investment Management LLC now owns 1,322,129 shares of the pharmacy operator’s stock worth $104,395,000 after buying an additional 1,307,100 shares in the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

Analyst Ratings Changes

A number of research firms have recently weighed in on CVS. Baird R W raised CVS Health to a “hold” rating in a research report on Thursday, May 30th. Wells Fargo & Company decreased their price objective on CVS Health from $76.00 to $60.00 and set an “equal weight” rating for the company in a research note on Tuesday, May 7th. TD Cowen lowered shares of CVS Health from a “buy” rating to a “hold” rating and cut their target price for the stock from $99.00 to $59.00 in a research note on Tuesday, May 7th. Mizuho lowered their price target on shares of CVS Health from $86.00 to $72.00 and set a “buy” rating for the company in a report on Thursday, May 2nd. Finally, Leerink Partnrs lowered shares of CVS Health from an “outperform” rating to a “market perform” rating in a report on Wednesday, May 1st. Eleven research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. According to MarketBeat.com, CVS Health currently has a consensus rating of “Moderate Buy” and an average price target of $75.05.

CVS Health Stock Performance

CVS traded down $2.27 during trading on Thursday, hitting $58.37. The stock had a trading volume of 16,221,576 shares, compared to its average volume of 12,083,041. The firm has a market capitalization of $73.27 billion, a P/E ratio of 10.22, a PEG ratio of 0.58 and a beta of 0.53. The company has a debt-to-equity ratio of 0.78, a quick ratio of 0.61 and a current ratio of 0.81. CVS Health Co. has a twelve month low of $52.77 and a twelve month high of $83.25. The company’s 50-day moving average price is $60.00 and its 200 day moving average price is $70.38.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, May 1st. The pharmacy operator reported $1.31 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.69 by ($0.38). The firm had revenue of $88.44 billion for the quarter, compared to analyst estimates of $89.33 billion. CVS Health had a return on equity of 13.53% and a net margin of 2.03%. The company’s revenue was up 3.7% compared to the same quarter last year. During the same quarter last year, the firm earned $2.20 earnings per share. On average, equities research analysts forecast that CVS Health Co. will post 7.02 EPS for the current fiscal year.

Insider Activity

In related news, Director Edward J. Ludwig acquired 1,000 shares of CVS Health stock in a transaction that occurred on Thursday, May 2nd. The stock was purchased at an average price of $53.88 per share, for a total transaction of $53,880.00. Following the completion of the purchase, the director now directly owns 21,630 shares of the company’s stock, valued at $1,165,424.40. The purchase was disclosed in a document filed with the SEC, which is available through the SEC website. Insiders own 0.24% of the company’s stock.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.